Slope of change in HbA 1c from baseline with empagliflozin compared with sitagliptin or glimepiride...
Slope of change in HbA 1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes
About this item
Full title
Author / Creator
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
To analyse the effect of baseline glycated haemoglobin (HbA
) on the reduction in HbA
with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes.
Using regression analyses of individual patient data from two Phase III studies, we compared the change in HbA
according to a unit change in baseline HbA
(...
Alternative Titles
Full title
Slope of change in HbA 1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2266870620
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2266870620
Other Identifiers
ISSN
2398-9238
E-ISSN
2398-9238
DOI
10.1002/edm2.16
